Structural characterization of human cytochrome P450 2C19: active site differences between P450s 2C8, 2C9, and 2C19.

Area of Science:

• Biochemistry
• Structural Biology
• Pharmacology

Background:

• Cytochrome P450 enzymes (CYP450s) are crucial for drug metabolism.
• CYP450 2C19 exhibits distinct substrate and inhibitor profiles compared to related enzymes like CYP450 2C8 and CYP450 2C9.
• Understanding these differences is key for predicting drug interactions and optimizing drug design.

Purpose of the Study:

• To elucidate the structural basis for the differential substrate and inhibitor recognition of CYP450 2C19.
• To compare the active site architecture of CYP450 2C19 with those of CYP450 2C8 and CYP450 2C9.

Main Methods:

• X-ray crystallography was employed to determine the atomic structure of CYP450 2C19 in complex with an inhibitor.
• The determined structure (PDB ID: 4GQS) was analyzed and compared to existing structures of related CYP450 enzymes.

Main Results:

• The peptide backbone conformation of CYP450 2C19 closely resembles that of CYP450 2C8.
• Significant differences in the substrate-binding cavity size and shape were observed between CYP450 2C19 and CYP450 2C8, attributed to varying amino acid residues.
• The active site cavity of CYP450 2C19 shows greater similarity in size to CYP450 2C9, but distinct differences arise from dissimilar helix B-C loop conformations.

Conclusions:

• The structural variations, particularly in the substrate-binding cavity and helix B-C loops, underlie the distinct pharmacological profiles of CYP450 2C19.
• The determined structure of CYP450 2C19 provides a foundation for computational studies predicting substrate and inhibitor interactions.